A clinical trial to evaluate the efficacy of Infliximab-abda in patients hospitalized with hypoxic respiratory failure and COVID-19 pneumonia
Latest Information Update: 07 Feb 2022
At a glance
- Drugs Infliximab (Primary)
- Indications COVID-19 pneumonia; Hypoxic respiratory failure
- Focus Therapeutic Use
Most Recent Events
- 07 Feb 2022 New trial record